The Latest Analyst Ratings for LifeMD
Portfolio Pulse from Benzinga Insights
LifeMD (NASDAQ:LFMD) received 5 analyst ratings in the last quarter, with 2 bullish and 3 somewhat bullish, and none bearish. The 12-month average price target for LifeMD is $8.8, with a high of $10.00 and a low of $7.00. This target has increased by 10% over the past month. Analyst ratings are provided quarterly and can influence stock performance.
November 30, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
LifeMD has a positive outlook from analysts with 5 ratings in the last quarter, leaning towards bullish. The average price target is $8.8, marking a 10% increase from the previous month.
The positive analyst ratings and the increase in the average price target over the past month indicate a favorable perception of LifeMD's stock among analysts. This could lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100